Terazosin (Page 7 of 7)

PRINCIPAL DISPLAY PANEL

pdp
(click image for full-size original)

TERAZOSIN terazosin hydrochloride capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:66267-325(NDC:59746-385)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TERAZOSIN HYDROCHLORIDE (TERAZOSIN) TERAZOSIN 5 mg
Inactive Ingredients
Ingredient Name Strength
GELATIN
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM LAURYL SULFATE
TITANIUM DIOXIDE
STARCH, CORN
SILICON DIOXIDE
D&C YELLOW NO. 10
D&C RED NO. 28
FD&C RED NO. 40
Product Characteristics
Color orange (Bright Orange Opaque) Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code TL385
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:66267-325-30 30 CAPSULE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075317 12/20/2004
Labeler — NuCare Pharmaceuticals, Inc. (010632300)
Establishment
Name Address ID/FEI Operations
NuCare Pharmaceuticals, Inc. 010632300 repack (66267-325)

Revised: 01/2022 NuCare Pharmaceuticals, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

https://medlibrary.org/lib/rx/meds/terazosin-17/page/7/

Clinical Trials

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.